Blog

//Blog

#Biomed2018: Gilead Buys Kite Pharma, Founded by Israelis, for $11.9 Billion

 Congratulations to Dr. Arie Belldegrun and Prof. Zelig Eshhar for an incredible achievement! Gilead Sciences agreed to 29 percent premium, which shrank fast in pretrading, despite biotech company Kite Pharma's low revenues, heavy R&D spending and losses Yoram Gabison Aug 29, 2017 The headquarters of Gilead Sciences in Foster City, California Credit: Eric Risberg, AP The almost [...]

By | 2017-08-29T09:06:46+00:00 August 29th, 2017|Blog|Comments Off on #Biomed2018: Gilead Buys Kite Pharma, Founded by Israelis, for $11.9 Billion

Mysterious Pediatric Neurological Disease Traced to a Single Gene Error

For the first time, scientists at Hebrew University of Jerusalem traced a rare neurological disorder in children to an error in a single gene. Led by Professor Orly Elpeleg, a geneticist and professor of Pediatrics at Hebrew University’s Faculty of Medicine, the international research team used deep sequencing technology to find a genetic anomaly representing [...]

By | 2017-08-20T10:24:06+00:00 August 20th, 2017|Blog|Comments Off on Mysterious Pediatric Neurological Disease Traced to a Single Gene Error

#Trump’s FDA Commissioner on #Drug #Prices, #Regulations, #Science

U.S. Food and Drug Administration Commissioner Scott Gottlieb spoke with Bloomberg News about drug pricing, new medicine and regulations. This transcript of the interview has been edited for clarity and length. Bloomberg: What’s the FDA’s role to play in drug pricing and what can the agency do, given that it hasn’t traditionally had a mandate to address [...]

By | 2017-07-31T07:03:41+00:00 July 31st, 2017|Blog|Comments Off on #Trump’s FDA Commissioner on #Drug #Prices, #Regulations, #Science

TEL AVIV – China’s appetite for high-tech investment and Israel’s emergence as a global innovation hub make them an ideal match

FEATURE: Pairing up Tech July 11, 2017 13:00 By China Daily/ANN TEL AVIV - China’s appetite for high-tech investment and Israel’s emergence as a global innovation hub make them an ideal match Chinese companies searching for high-tech investments are increasingly making their way to Israel, a country that in terms of innovation mirrors the East [...]

By | 2017-07-23T07:28:59+00:00 July 23rd, 2017|Blog|Comments Off on TEL AVIV – China’s appetite for high-tech investment and Israel’s emergence as a global innovation hub make them an ideal match

ISRAELI ROBOTICS COMPANY RECEIVES FUNDING FROM TOYOTA RESEARCH INSTITUTE

  Reuters July 11, 2017 Toyota leads $14 million funding round for Israel's Intuition Robotics Intuition Robotics, an Israeli developer of artificial intelligence robots for use by the elderly, said on Tuesday it raised $14 million in an early stage funding round led by the Toyota Research Institute (TRI). OurCrowd, iRobot, Maniv Mobility, Terra Venture [...]

By | 2017-07-16T10:14:32+00:00 July 16th, 2017|Blog, News|Comments Off on ISRAELI ROBOTICS COMPANY RECEIVES FUNDING FROM TOYOTA RESEARCH INSTITUTE

The company, which develops cures for early-onset life-threatening diseases, has emerged from stealth.

Gene-therapy company LogicBio Therapeutics, which develops cures for early-onset life-threatening diseases, has emerged from stealth to announce that it has raised $50 million in a financing round led by Arix Biosciences and with the particvipation of Edmond de Rothschild Investment Partners, Pontifax, and SBI Japan-Israel Innovation Fund. LogicBio also announced that it has relocated it headquarters [...]

By | 2017-07-02T06:08:04+00:00 July 2nd, 2017|Blog|Comments Off on The company, which develops cures for early-onset life-threatening diseases, has emerged from stealth.

Mitoconix Bio hits $20M series A for neurodegenerative R&D

by Ben Adams | Jun 27, 2017 Its tech is based around Stanford's work on mitochondrial function   Preclinical startup Mitoconix Bio has secured a $20 million series A round for its research work on neurological disorders, including its lead candidate for Huntington’s disease. The round was led by Remiges Ventures with help from OrbiMed, Dementia [...]

By | 2017-06-28T08:12:37+00:00 June 28th, 2017|Blog|Comments Off on Mitoconix Bio hits $20M series A for neurodegenerative R&D

Gamida Cell raises $40m

The financing round, led by new investor Shavit Capital, will support Gamida Cell's Phase 3 trial of its NiCord bone marrow transplantation product. Cell and immune therapy technologies company Gamida Cell has announced the signing of a $40 million financing to support the ongoing Phase 3 trial of the its FDA Breakthrough Designated clinical-stage product, [...]

By | 2017-06-20T08:15:04+00:00 June 20th, 2017|Blog|Comments Off on Gamida Cell raises $40m

Israeli Startup Wants to Cure Diabetes by Making Micro-pancreases. It Worked on Mice

Never mind better insulin shots or cell implants for diabetics: Betalin Therapeutics has a unique approach Ruth Schuster Jun 06, 2017 4:22 PM Mice can be cured of diabetes with Prof. Mitrani's micro-pancreas. Credit: Dreamstime.com A young Israeli company that has cured type-1 diabetes in mice and hopes to do the same for humans one [...]

By | 2017-06-07T08:06:22+00:00 June 7th, 2017|Blog|Comments Off on Israeli Startup Wants to Cure Diabetes by Making Micro-pancreases. It Worked on Mice